News Headline Summary

RANsquawk - Today's Trading Edge

NEWS: FDA approves Vanda's (VNDA) Hetlioz for treatment of non-24-hour disorder and sees it commercial available in Q2 of 2014
REACTION: In an immediate reaction, VNDA shares spiked 10.6% higher from USD 13.29 to USD 14.69

NEWS: The Business Journals writes "Men’s Wearhouse (MW) doesn't plan to extend Jos. A. Bank (JOSB) tender offer beyond March 28"
REACTION: In an immediate reaction, MW shares fell 1% from USD 47.66 to USD 47.17. JOSB shares fell 0.7% from USD 56.22 to USD 55.78

NEWS: For TransCanada Corp (TRP), US is said to find Keystone will not greatly boost oil sands output
REACTION: In an immediate reaction, TRP shares saw a knee-jerk reaction lower, initially falling by 1.04% from USD 43.30 to USD 42.85

NEWS: Minerals Technologies (MTX) sees Q1 EPS USD 0.56-58 vs. Exp. USD 0.63
REACTION: In an immediate reaction Co. shares fell 2.02% from USD 52.98 to 51.90.

NEWS: Alstom (ALO FP) wins EUR 1.25bln contract in Poland
REACTION: In the immediate reaction, ALO FP shares rose 1.68% from EUR 20.30 to EUR 20.64

NEWS: Negative Seeking Alpha article on Galena Pharmaceuticals (GALE)
REACTION: In the immediate reaction, GALE shares fell 2.1% in a move from USD 5.27 to USD 5.16

NEWS: RBNZ Wheeler says rates need to return to more normal levels, adjustment to begin soon, but high exchange rate is a headwind to growth
REACTION: Over the following 5 minutes, NZD/USD moved lower by 22 pips to 0.8153 from 0.8175

31 Jan 2014 - 21:04 - Equities - Source: RANsquawk

Subscribe Now to RANsquawk

Click here for a 1 week free trial

RANsquawk provides audio news and commentary for over 15,000 professional traders and brokers worldwide. Services include: